The Antihypertensive Effect of Rosiglitazone in Two-Kidneys-one-clip Hypertensive Rats

FU Chen-sheng,LIU Chun-feng,XU Shao-wei,ZHU Jia-ming,DING Xiao-qiang

DOI: https://doi.org/10.3969/j.issn.1672-8467.2006.06.022

2006-01-01

Abstract:Purpose To observe the effect of rosiglitazone on blood pressure in two-kidneys-one-clip hypertensive rats, and the relationship between reduction of blood pressure and modulation of blood glucose or lipids by rosiglitazone. Methods Twenty four two-kidneys-one-clip hypertensive rats were randomly assigned to 3 groups as follows: Positive control group(2K1C), rosiglitazone of 5 mg·kg~ -1 ·d~ -1 group(RGL5), and rosiglitazone of 20 mg·kg~ -1 ·d~ -1 group(RGL20). Eight sham rats were fed as negative controls(SHAM). Animals were monitored for their blood pressure and body weight every other week and sacrificed at 10 th week. Fast serum cholesterol, triglyceride and glucose were investigated before and after intervention. Results Compared with 2K1C group, RGL5 had no significant differences in blood pressure and the blood pressure of RGL20 decreased since the 2nd week(P 0.05 ). After the intervention, RGL5 and RGL20 had the lower level of triglyceride compared with 2K1C(P0.05), however, no difference of triglyceride was found between RGL5 and RGL20. Conclusions Rosiglitazone of 5 mg·kg~ -1 ·d~ -1 can decrease the level of triglyceride of 2K1C rats, but not their blood pressure. Rosiglitazone of 20 mg·kg~ -1 ·d~ -1 not only decreased the level of triglyceride of 2K1C rats, but also their blood pressure. The decrease of blood pressure by rosiglitazone of 20 mg·kg~ -1 ·d~ -1 may not completely depend on its effects of modulating glucose or lipid metabolism.